Navigation Links
Progress after recent breakthrough which opened new chapter in anti-cancer cell therapies
Date:5/22/2013

May 22, 2012 (Hackensack, NJ) John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will bring together leading cancer experts, for presentation and discussion of the latest developments and implications of cell therapy and interventional immunology in oncology, on Friday, June 7 from 7:00am to 1:30pm.

"I'm excited to bring together some of the nation's top immunology experts to review the latest developments and implications of cell therapies in oncology, both in solid and liquid tumors," said Andre Goy M.D., Cancer Center Director, and Chief of lymphoma, John Theurer Cancer Center and Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates. "This will provide an opportunity to see where the field is going and discuss some of the mechanisms and applications of T-cell manipulation as a promising tool against a number of cancers. The preliminary results seen with these modified T-cells will likely be revolutionary in the treatment of cancer".

The conference, titled "Cell Therapy and Interventional Immunology: Current Developments and Implications", is designed for hematologists, oncologists, physicians, and medical professionals. Given the enormous impact and growing interest in those therapies, the conference will also be offered to patients and caregivers through live online streaming. Speakers will cover the biology and manufacturing aspects of the chimeric antigenic receptor (CAR) modified T-cells as well as other manipulation of T-cells and the immune system, which for the first time, seem to be translating into impressive activity in the clinic.

The conference speakers and presentations include:

  • Catherine Bollard, MBChB, M.D., Professor of Pediatrics, Medicine, and Pathology & Immunology, Texas Children's Cancer Center, Baylor College of Medicine: Anti-EBV T-Cells and CAR T-Cells and Their Applications in Hematological Malignancies
  • Renier J. Brentjens, M.D., Ph.D., Leukemia Service, Memorial Sloan-Kettering Cancer Center: CAR Modified T-Cells for the Treatment of Cancer: Preclinical and Clinical Outcomes
  • Daniel H. Fowler M.D., Senior Investigator, Center for Cancer Research. National Cancer Institute: TH-2 Amplification and Other strategies to Reduce GVHD and Improve Outcome in Allogeneic Transplantations.
  • James N. Kochenderfer, M.D., Assistant Clinical Investigator, Center for cancer Research, National Cancer Institute: Autologous and Donor Derived Anti-CD19 CAR T-Cells Applications in non-Hodgkin Lymphoma and CLL
  • Cameron J. Turtle, M.D., Ph.D., Acting Instructor, University of Washington and Research Associate, Fred Hutchinson Cancer Research Center: Engineered Antigen Presenting Cells and T-Cells for Anti-Cancer Therapy

"Conferences such as this help physicians, medical professionals, as well as patients and caregivers to gain a better understanding of promising new treatment options, resulting in better clinical outcomes," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer, Professor, and Vice President of Cancer Services and President of Regional Cancer Care Associates, "John Theurer Cancer Center is committed to providing these conferences to improve patient care and education."


'/>"/>

Contact: Amy Leahing
ALeahing@hackensackumc.org
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency
2. Mirena IUD Lawyers at Gilman Law LLP, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Anticipates Progress in Newly Established Mirena Federal Litigation
3. 30 Years of Orphan Drug Act, Combined with Science and Advocacy, Reflect Dramatic Progress in a Rare Lung Disease, Pulmonary Hypertension Association Says
4. Study evaluates effect of different supplements on reducing risk of progression to advanced AMD
5. Nina Brown Launches New Website for Spiritual Progressives
6. Despite superbug crisis, progress in antibiotic development alarmingly elusive
7. Progressive Dental Marketing Is Bringing Online Dental Marketing to Oregon for Dental Professionals Specializing in Laser Dentistry and Dental Implants
8. New findings on the brains immune cells during Alzheimers disease progression
9. Progressive Dental Marketing Is Bringing Online Dental Marketing to Oregon for Dental Professionals Specializing in Laser Dentistry and Dental Implants
10. Progressive Dental Marketing Is Bringing Online Dental Marketing to Washington for Dental Professionals Specializing in Laser Dentistry and Dental Implants
11. Progressive Dental Marketing Is Bringing Online Dental Marketing to Vancouver, B.C. for Dental Professionals Specializing in Laser Dentistry and Dental Implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... ... July 22, 2020 , ... Whatever we call them ... people may like a summer glow,” notes Angie Seelal, a Certified Registered Physician Assistant ... spots that show up years later and make us look older.” , In terms ...
(Date:7/22/2020)... ... July 22, 2020 , ... ... launch of its new Data Curation as a Service (DCaaS) solution for payers, ... focus on specific clinical data curation parameters and are custom tailored to provide ...
(Date:7/18/2020)... ... July 17, 2020 , ... Nader Sanai, M.D., director ... have come together for the second annual Glioblastoma Awareness Day (#GBMDay) on July 22, ... to increasing public awareness of glioblastoma , the most common and aggressive form ...
(Date:7/10/2020)... ... July 10, 2020 , ... Inversion therapy is defined by ... the spine and relieve back pain.” Ergo, the theory is that if the body’s ... implementing traction for the spine using the head and upper body as the "weights" ...
(Date:7/10/2020)... ... ... Ziegler, a specialty investment bank, is pleased to announce the successful closing of ... (Beacon Hill). The Series 2020 Bank Bonds include a $9,800,000 long-term component with ... be retired with initial entrance fees from the Project (detailed below). , ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 31, 2020 , ... ... received FDA clearance for reprocessing the St. Jude Medical BRK Transseptal Needle and ... transseptal needles is a milestone in single-use device reprocessing, as no other company ...
(Date:7/31/2020)... (PRWEB) , ... July 31, 2020 , ... Member Care ... the nation’s largest urgent care clinic operators the licensing of their cloud based membership ... the Member Care Solutions client family. Our software is the perfect match for many ...
(Date:7/31/2020)... ... July 31, 2020 , ... A June 29 article ... to have been caused by tiny worms that inhabited the mouths of those afflicted. ... details of small creatures that are commonly found in water supplies. Marina Del Rey-based ...
Breaking Medicine Technology: